Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Current perspectives on pediatric inflammatory bowel disease focusing on transitional care management. What should we consider?
Constanza Bay M; Paulina Núñez F; Rodrigo Quera; Andrés J. Yarur;
Gastroenterol Hepatol. 2023;46:139-47
De-escalating therapy in inflammatory bowel disease: Results from an observational study in clinical practice
Alex Arenas; María José Moreta; Ingrid Ordás; Agnès Fernández-Clotet; Berta Caballol; Marta Gallego; Alejandro Vara; Rebeca Barastegui; Angel Giner; Cristina Prieto; Maria Carme Masamunt; Roberto Candia; Elena Ricart;
Gastroenterol Hepatol. 2024;47:673-82
Therapeutic drug monitoring in inflammatory bowel diseases. Position statement of the Spanish Working Group on Crohn¿s Disease and Ulcerative Colitis
Francisco Rodríguez-Moranta; Federico Argüelles-Arias; Joaquín Hinojosa del Val; Marisa Iborra Colomino; M. Dolores Martín-Arranz; Luis Menchén Viso; Fernando Muñoz Núñez; Elena Ricart Gómez; José Germán Sánchez-Hernández; Teresa Valdés-Delgado; Jordi Guardiola Capón; Manuel Barreiro-de Acosta; Míriam Mañosa Ciria; Yamile Zabana Abdo; Ana Gutiérrez Casbas;
Gastroenterol Hepatol. 2024;47:522-52